Does ROSUVASTATIN Cause Bronchial secretion retention? 97 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 97 reports of Bronchial secretion retention have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.3% of all adverse event reports for ROSUVASTATIN.
97
Reports of Bronchial secretion retention with ROSUVASTATIN
0.3%
of all ROSUVASTATIN reports
0
Deaths
97
Hospitalizations
How Dangerous Is Bronchial secretion retention From ROSUVASTATIN?
Of the 97 reports, 97 (100.0%) required hospitalization.
Is Bronchial secretion retention Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 97 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Bronchial secretion retention?
ALBUTEROL (374)
TIOTROPIUM (295)
PREDNISONE (268)
MONTELUKAST (240)
MEPOLIZUMAB (209)
BUDESONIDE (182)
OMALIZUMAB (171)
FUROSEMIDE (169)
BISOPROLOL (163)
BUDESONIDE\FORMOTEROL (156)
Which ROSUVASTATIN Alternatives Have Lower Bronchial secretion retention Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN